FDA approves new diet drug: Phentermine-Topiramate Combo

Health Care, Medicine Comments Off

The US FDA has approved the weight-loss drug Qsymia  which now joins lorcaserin as the first anti-obesity medications to enter the US market since 1999.

Qsymia, a controlled-release preparation of phentermine and topiramate in one capsule, is indicated for use in adults with a body mass index (BMI) >30 kg/m2 or adults with a BMI of >27 kg/m2 and at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.

Physical inactivity causes to one in 10 premature deaths worldwide

Health Care Comments Off

Physical inactivity kills. It is causing about one in 10 premature deaths around the world annually as per a report in July 18 in The Lancet. The problem of inactivity is like a pandemic.

Globally physical inactivity is associated with 6% of the incidence of coronary heart disease (range 3.2% to 7.8%), 7% of type 2 diabetes incidence (range 3.9% to 9.6%), 10% of breast cancer incidence (range 5.6% to 14.1%) and 10% of colon cancer incidence (range 5.7% to 13.8%).

People in higher income countries are the least active with those in the UK among the worst as nearly two-thirds of adults are judged not to be doing enough.